Advanced search
Publication Cover
HIV Clinical Trials Volume 4, 2003 - Issue 5
Submit an article Journal homepage
30
Views
11
CrossRef citations to date
0
Altmetric
Original Articles

Clinical Impact of Double Protease Inhibitor Boosting with Lopinavir/Ritonavir and Amprenavir as Part of Salvage Antiretroviral Therapy

Mona LoutfyImmune Deficiency Treatment Centre, Montreal General Hospital, McGill University, Montreal, Quebec;Division of Infectious DiseasesUniversity Health Network, Toronto, Ontario
,
Janet RaboudDepartment of MedicineUniversity of Toronto, Toronto, Ontario;Division of Infectious DiseasesUniversity Health Network, Toronto, Ontario
,
Courtney ThompsonDivision of Infectious DiseasesUniversity Health Network, Toronto, Ontario
,
Alice TsengDivision of Infectious DiseasesUniversity Health Network, Toronto, Ontario
,
Zainab AbdurrahmanDepartment of Statistics and Actuarial ScienceUniversity of Waterloo, Waterloo, Ontario
,
Colin KovacsDepartment of MedicineUniversity of Toronto, Toronto, Ontario;Canadian Immunodeficiency Research CollaborativeToronto, Ontario
,
Anita RachlisDepartment of MedicineUniversity of Toronto, Toronto, Ontario;Division of Infectious DiseasesSunnybrook and Women's College Health Sciences Centre, Toronto, Ontario
,
Elizabeth PhillipsDepartment of MedicineUniversity of Toronto, Toronto, Ontario;Division of Infectious DiseasesSunnybrook and Women's College Health Sciences Centre, Toronto, Ontario
,
Gary RubinCanadian Immunodeficiency Research CollaborativeToronto, Ontario
,
Kevin GoughDepartment of MedicineUniversity of Toronto, Toronto, Ontario;St. Michael's HospitalToronto, Ontario, Canada
&
Sharon WalmsleyDepartment of MedicineUniversity of Toronto, Toronto, Ontario;Division of Infectious DiseasesUniversity Health Network, Toronto, OntarioCorrespondence[email protected]
 show all
Pages 301-310 | Published online: 02 Feb 2015

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Ann C. Collier, Camlin Tierney, Gerald F. Downey, Susan H. Eshleman, Angela Kashuba, Karin Klingman, Emanuel N. Vergis, Gary E. Pakes, James F. Rooney, Alex Rinehart & John W. Mellors. (2008) Randomized Study of Dual Versus Single Ritonavir-Enhanced Protease Inhibitors for Protease Inhibitor-Experienced Patients with HIV. HIV Clinical Trials 9:2, pages 91-102.
Read now
Darrell Tan & Sharon Walmsley. (2007) Lopinavir plus ritonavir: a novel protease inhibitor combination for HIV infections. Expert Review of Anti-infective Therapy 5:1, pages 13-28.
Read now
Suresh Katragadda, Balasubrahmanyam Budda, Banmeet S Anand & Ashim K Mitra. (2005) Role of efflux pumps and metabolising enzymes in drug delivery. Expert Opinion on Drug Delivery 2:4, pages 683-705.
Read now
Graham H.R. Smith, Mohamed-Rachid Boulassel, Marina Klien, Nobert Gilmore, Jean MacLeod, Roger LeBlanc, Pierre René, Jean-Pierre Routy & Richard G. Lalonde. (2005) Virologic and Immunologic Response to a Boosted Double-Protease Inhibitor-Based Therapy in Highly Pretreated HIV-1-Infected Patients. HIV Clinical Trials 6:2, pages 63-72.
Read now

Articles from other publishers (7)

Regina B. OsihPatrick TafféMartin RickenbachAngèle Gayet–AgeronLuigia ElziChristoph FuxMilos OpravilEnos BernasconiPatrick SchmidHuldrych F GünthardMatthias Cavassini. (2010) Outcomes of Patients on Dual-Boosted PI Regimens: Experience of the Swiss HIV Cohort Study. AIDS Research and Human Retroviruses 26:11, pages 1239-1246.
Crossref
Krittaecho SiripassornWeerawat ManosuthiSuthat ChottanapundAranya PakdeeSiriwan SabaitaeWisit PrasithsirikulPreecha TunthanathipKiat Ruxrungtham. (2010) Effectiveness of Boosted Protease Inhibitor-Based Regimens in HIV Type 1-Infected Patients Who Experienced Virological Failure with NNRTI-Based Antiretroviral Therapy in a Resource-Limited Setting. AIDS Research and Human Retroviruses 26:2, pages 139-148.
Crossref
Maya L Petersen, Yue Wang, Mark J van der Laan, Soo-Yon Rhee, Robert W Shafer & W Jeffrey Fessel. (2007) Virologic efficacy of boosted double versus boosted single protease inhibitor therapy. AIDS 21:12, pages 1547-1554.
Crossref
Marta Boffito, Laura Dickinson, Andrew Hill, David Back, Graeme Moyle, Mark Nelson, Chris Higgs, Carl Fletcher, Brian Gazzard & Anton Pozniak. (2004) Steady-State Pharmacokinetics of Saquinavir Hard-Gel/Ritonavir/Fosamprenavir in HIV-1???Infected Patients. JAIDS Journal of Acquired Immune Deficiency Syndromes 37:3, pages 1376-1384.
Crossref
Jean-Marie Poirier, Jean-Luc Meynard, Ouahiba Zouai & Patrice Jaillon. (2004) Intérêt et limites du suivi thérapeutique des inhibiteurs de la protéase du VIH. Revue Française des Laboratoires 2004:365, pages 67-72.
Crossref
Gilles Raguin, Geneviève Chêne, Laurence Morand-Joubert, Anne-Marie Taburet, Cécile Droz, Clotilde Le Tiec, François Clavel, Pierre-Marie Girard, W Rozenbaum, L Naït-Ighil, TH Nguyen, L Slama, PM Girard, JM Molina, D Sereni, N Colin de Verdière, C Lascoux-Combes, C Pintado, D Ponscarme, F Prevoteau de Clary, M Tourneur, M Bentata, L Guillevin, O Launay, R Mansouri, F Rouges, M Kazatchkine, A Aouba, M Azizi, JN Fiessinger, P Le Houssine, D Sicard, C Bernasconi, D Salmon, B Silbermann, JP Cassuto, C Ceppi, Dr Poiree, G Raguin, M Merad, JF Delfraissy, C Goujard, Y Quertainmont, C Perronne, P de Truchis, B Dupont, JL Bresson, I Calatroni, F RaffiJL EsnaultS Leautez. (2003) Salvage Therapy with Amprenavir, Lopinavir and Ritonavir 200 Mg/D or 400 Mg/D in HIV-Infected Patients in Virological Failure. Antiviral Therapy 9:4, pages 615-625.
Crossref
José AntonioIribarren, Pablo Labarga, Rafael Rubio, Juan Berenguer, JoséM. Miró, Antonio Antela, Juan González, Santiago Moreno, Julio Arrizabalaga, Lourdes Chamorro, Bonaventura Clotet, José M. Gatell, José López-Aldeguer, Esteban Martínez, Rosa Polo, Montserrat Tuset, Pompeyo Viciana, Juan Miguel Santamaría, José María Kindelán, Esteve Ribera & Ferrán Segura. (2004) Recomendaciones de GESIDA/Plan Nacional sobre el Sida respecto al tratamiento antirretroviral en pacientes adultos infectados por el VIH (octubre 2004). Enfermedades Infecciosas y Microbiología Clínica 22:10, pages 564-642.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.